alpha-aminopyridine has been researched along with Bone Loss, Osteoclastic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Chen, J; Chen, Q; Gu, H; Guo, X; He, D; He, H; He, J; Huang, X; Wang, G; Yan, H; Yang, Y; Yi, Q; Zhang, E; Zhao, Y | 1 |
| Ge, XT; Guo, JX; Li, CL; Li, TY; Lv, F; Wang, XF; Wang, YJ | 1 |
| Banquerigo, ML; Brahn, E; Chang, B; Grossbard, EB; Lau, A; Payan, DG; Pine, PR; Schoettler, N; Wang, S; Zhao, F | 1 |
| Krieger, NS; Stern, PH | 1 |
| Bradbeer, JN; Drake, FH; Erhard, KF; Gowen, M; Huffman, WF; Hwang, SM; James, IE; Lark, MW; Mathur, A; Miller, WH; Newlander, KA; Rieman, DJ; Ross, ST; Salyers, KL; Smith, BR; Stroup, GB | 1 |
| Krieger, NS; Stathopoulos, VM; Stern, PH | 1 |
6 other study(ies) available for alpha-aminopyridine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease.
Topics: Aminopyridines; Animals; Apoptosis; Benzamides; Bone Diseases; Bone Resorption; Cell Cycle Checkpoints; Cell Line, Tumor; Cells, Cultured; Histone Deacetylase Inhibitors; Humans; Mice; Multiple Myeloma; Osteoblasts; Osteoclasts | 2018 |
Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.
Topics: Aminopyridines; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Cancellous Bone; Disease Models, Animal; Lipopolysaccharides; Male; Osteoclasts; Osteoporosis; Pyrroles; Rats, Sprague-Dawley; Receptor, Macrophage Colony-Stimulating Factor; Tibia | 2019 |
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor.
Topics: Aminopyridines; Animals; Arthritis, Rheumatoid; Arthus Reaction; Bone Resorption; Collagen Type II; Disease Models, Animal; Female; Immunoglobulin G; Inflammation; Intracellular Signaling Peptides and Proteins; Morpholines; Oxazines; Prodrugs; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, IgG; Signal Transduction; Syk Kinase; Synovial Fluid; Synovitis | 2007 |
Interaction between amrinone and parathyroid hormone on bone in culture.
Topics: Aminopyridines; Amrinone; Animals; Animals, Newborn; Bone and Bones; Bone Resorption; Calcitonin; Cardiotonic Agents; Cells, Cultured; Kinetics; Mice; Nigericin; Ouabain; Parathyroid Hormone | 1982 |
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Topics: Acetates; Administration, Oral; Aminopyridines; Animals; Bone Resorption; Cell Adhesion; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Infusions, Intravenous; Integrins; Osteoporosis; Ovariectomy; Parathyroidectomy; Platelet Aggregation; Protein Binding; Rats; Receptors, Vitronectin; Thyroidectomy; Time Factors | 1999 |
Does amrinone inhibition of stimulated bone resorption involve Na+-Ca++ exchange?
Topics: Aminopyridines; Amrinone; Animals; Bone Resorption; Calcium; Cardiotonic Agents; Cycloheximide; Dactinomycin; Hydroxyurea; In Vitro Techniques; Ion Exchange; Leucine; Mice; Parathyroid Hormone; Rats; Rats, Inbred Strains; Sodium; Thymidine; Uridine | 1986 |